Recent developments and future directions in Guillain-Barré syndrome
作者： Helmar C. Lehmann , Richard A. C. Hughes , Bernd C. Kieseier , Hans-Peter Hartung
DOI: 10.1111/J.1529-8027.2012.00433.X
关键词:
摘要: Guillain-Barre syndrome (GBS) encompasses a spectrum of acquired neuropathic conditions characterized by inflammatory demyelinating or axonal peripheral neuropathy with acute onset. Clinical and experimental studies in the past years have led to substantial progress epidemiology, pathogenesis GBS variants, identification prognostic factors relevant treatment. In this review we provide an overview critical assessment most recent developments future directions research.
sci-hub.se 参考文章(188)
R. Press, M. Pashenkov, J.-P. Jin, H. Link, Aberrated levels of cerebrospinal fluid chemokines in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. Journal of Clinical Immunology. ,vol. 23, pp. 259- 267 ,(2003) , 10.1023/A:1024532715775
C A M Huisman, M R Schipperus, P W Wijermans, B A P Laros-van Gorkom, Experience with alemtuzumab in treatment of chronic lymphocytic leukaemia in the Netherlands. Netherlands Journal of Medicine. ,vol. 65, pp. 333- 338 ,(2007)
Susumu Kusunoki, Ken-ichi Kaida, Antibodies against ganglioside complexes in Guillain-Barré syndrome and related disorders. Journal of Neurochemistry. ,vol. 116, pp. 828- 832 ,(2011) , 10.1111/J.1471-4159.2010.07029.X
Frank DeStefano, Jerome Tokars, H1N1 vaccine safety monitoring: beyond background rates The Lancet. ,vol. 375, pp. 1146- 1147 ,(2010) , 10.1016/S0140-6736(09)61917-6
Alberto Carmona, Juan Domingo Alonso, Manuel de las Heras, Agustín Navarrete, Guillain-Barre syndrome in a patient with diffuse large B-cell lymphoma, and rituximab maintenance therapy. An association beyond anecdotal evidence? Clinical & Translational Oncology. ,vol. 8, pp. 764- 766 ,(2006) , 10.1007/S12094-006-0126-5
Fabrizia Terenghi, Gianluca Ardolino, Eduardo Nobile-Orazio, Guillain-Barré syndrome after combined CHOP and rituximab therapy in non-Hodgkin lymphoma. Journal of The Peripheral Nervous System. ,vol. 12, pp. 142- 143 ,(2007) , 10.1111/J.1529-8027.2007.00134.X
Luis F Marin, Ayessandro Abrahão, Flavio A Carvalho, William AC Santos, Cleber C Dallalba, Lorena B Barcelos, Gisele S Silva, Acary SB Oliveira, None, Guillain-Barré syndrome associated with H1N1 vaccination. Arquivos De Neuro-psiquiatria. ,vol. 68, pp. 974- 975 ,(2010) , 10.1590/S0004-282X2010000600029
Shu Li Xiang, Min Zhong, Fang Cheng Cai, Bing Deng, Xiao Ping Zhang, The sialic acid residue is a crucial component of C. jejuni lipooligosaccharide ganglioside mimicry in the induction Guillain-Barré syndrome Journal of Neuroimmunology. ,vol. 174, pp. 126- 132 ,(2006) , 10.1016/J.JNEUROIM.2006.02.009
Ken-ichi Kaida, Mami Kanzaki, Daiji Morita, Keiko Kamakura, Kazuo Motoyoshi, Minako Hirakawa, Susumu Kusunoki, Anti-ganglioside complex antibodies in Miller Fisher syndrome Journal of Neurology, Neurosurgery, and Psychiatry. ,vol. 77, pp. 1043- 1046 ,(2006) , 10.1136/JNNP.2006.087940
Pier Paolo Sainaghi, Laura Collimedaglia, Federica Alciato, Maurizio A. Leone, Paola Naldi, Rossella Molinari, Francesco Monaco, Gian Carlo Avanzi, The expression pattern of inflammatory mediators in cerebrospinal fluid differentiates Guillain-Barré syndrome from chronic inflammatory demyelinating polyneuropathy. Cytokine. ,vol. 51, pp. 138- 143 ,(2010) , 10.1016/J.CYTO.2010.05.005